A new Fact Sheet is now available to download from HUB Organoids (now part of Merck).

Get earlier, mechanistic insight into DILI risk with HUB Organoids’ human liver organoid platform:

  • Donor-diverse liver organoid biobank
  • Multiparametric live-cell assay: mitochondrial dysfunction, oxidative stress, lipid dysregulation,viability
  • Supports lead optimisation and safer candidate selection in preclinical development

Download your copy.